肿瘤内BRAFV600E异质性与激酶抑制剂在甲状腺癌治疗中的应用：征集参与研究 - Suppr

Suppr

超能文献

Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: a call for participation.

作者信息

Vitale Mario

出版信息

Thyroid. 2013 Apr;23(4):517-9. doi: 10.1089/thy.2012.0614. Epub 2013 Mar 15.

DOI:10.1089/thy.2012.0614

PMID:23398043

Abstract

摘要

相似文献

Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: a call for participation.肿瘤内BRAFV600E异质性与激酶抑制剂在甲状腺癌治疗中的应用：征集参与研究

Thyroid. 2013 Apr;23(4):517-9. doi: 10.1089/thy.2012.0614. Epub 2013 Mar 15.

Clinical development of kinase inhibitors for the treatment of differentiated thyroid cancer.用于治疗分化型甲状腺癌的激酶抑制剂的临床开发。

Clin Adv Hematol Oncol. 2011 Jan;9(1):32-41.

Receptor tyrosine kinase inhibitors in thyroid cancer.甲状腺癌中的受体酪氨酸激酶抑制剂

Best Pract Res Clin Endocrinol Metab. 2008 Dec;22(6):1023-38. doi: 10.1016/j.beem.2008.09.012.

Lenvatinib (Lenvima) for thyroid cancer.乐伐替尼（乐卫玛）用于治疗甲状腺癌。

Med Lett Drugs Ther. 2015 Aug 17;57(1475):e120-1.

An internist's approach to cancer diseases based on the model of thyroid cancer treated with tyrosine kinase inhibitors.

Pol Arch Med Wewn. 2016 Nov 30;126(11):925-928. doi: 10.20452/pamw.3677.

Lenvatinib approved for certain thyroid cancers.仑伐替尼获批用于特定甲状腺癌。

Cancer Discov. 2015 Apr;5(4):338. doi: 10.1158/2159-8290.CD-NB2015-029. Epub 2015 Feb 26.

Emerging therapies for thyroid carcinoma.甲状腺癌的新兴疗法。

Surgeon. 2012 Feb;10(1):53-8. doi: 10.1016/j.surge.2011.08.004. Epub 2011 Sep 9.

Trial watch: Multikinase-targeting therapy finds potential niche in thyroid cancer.试验观察：多激酶靶向治疗在甲状腺癌中发现潜在应用领域。

Nat Rev Drug Discov. 2015 Apr;14(4):229. doi: 10.1038/nrd4599.

Molecular targeted therapies for patients with refractory thyroid cancer.难治性甲状腺癌患者的分子靶向治疗。

Clin Oncol (R Coll Radiol). 2010 Aug;22(6):448-55. doi: 10.1016/j.clon.2010.04.008.

Therapeutic management of metastatic medullary thyroid carcinoma: role of new tyrosine kinase inhibitors.转移性甲状腺髓样癌的治疗管理：新型酪氨酸激酶抑制剂的作用

Endocrinol Nutr. 2013 Mar;60(3):152-3. doi: 10.1016/j.endonu.2012.02.008. Epub 2012 May 6.

引用本文的文献

Intra-tumor heterogeneity, turnover rate and karyotype space shape susceptibility to missegregation-induced extinction.肿瘤内异质性、周转率和核型空间影响易位诱导灭绝的敏感性。

PLoS Comput Biol. 2023 Jan 23;19(1):e1010815. doi: 10.1371/journal.pcbi.1010815. eCollection 2023 Jan.

BRAF Mutation: Has It a Role in Cervical Lymph Node Metastasis of Papillary Thyroid Cancer?BRAF突变：它在甲状腺乳头状癌颈淋巴结转移中起作用吗？

Eur Thyroid J. 2016 Sep;5(3):195-200. doi: 10.1159/000448112. Epub 2016 Aug 20.

Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.肿瘤内异质性程度及后果的泛癌分析

Nat Med. 2016 Jan;22(1):105-13. doi: 10.1038/nm.3984. Epub 2015 Nov 30.

Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma.BRAF V600E突变与甲状腺乳头状癌区域淋巴结转移之间的关联。

Int J Clin Exp Pathol. 2015 Jan 1;8(1):793-9. eCollection 2015.

Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe.使用自制四色探针优化甲状腺肿瘤细胞中 RET 和 PPARg 重排的检测。

Cancer Cytopathol. 2014 May;122(5):377-85. doi: 10.1002/cncy.21397. Epub 2014 Feb 7.

Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients.BRAFV600E突变检测在老年患者甲状腺结节中的诊断效用

BMC Surg. 2013;13 Suppl 2(Suppl 2):S37. doi: 10.1186/1471-2482-13-S2-S37. Epub 2013 Oct 8.

Early cytological diagnosis of extranodal stage I, primary thyroid Non-Hodgkin lymphoma in elderly patients. Report of two cases and review of the literature.老年患者结外I期原发性甲状腺非霍奇金淋巴瘤的早期细胞学诊断。两例报告并文献复习。

BMC Surg. 2013;13 Suppl 2(Suppl 2):S49. doi: 10.1186/1471-2482-13-S2-S49. Epub 2013 Oct 8.

Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.间变性甲状腺癌治疗中的基因突变：一项系统评价

BMC Surg. 2013;13 Suppl 2(Suppl 2):S44. doi: 10.1186/1471-2482-13-S2-S44. Epub 2013 Oct 8.

Nodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literature.老年患者结节性甲状腺肿伴淀粉样沉积：细针穿刺细胞学诊断及文献复习

BMC Surg. 2013;13 Suppl 2(Suppl 2):S43. doi: 10.1186/1471-2482-13-S2-S43. Epub 2013 Oct 8.

BRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay.通过焦磷酸测序法对合并桥本甲状腺炎的甲状腺结节细针穿刺样本进行BRAF（V600E）评估是一种可靠的检测方法。

Endocrine. 2014 Mar;45(2):249-55. doi: 10.1007/s12020-013-9994-y. Epub 2013 Jun 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验